Positron Emission Tomography - Current Clinical and Research Aspects 2012
DOI: 10.5772/29352
|View full text |Cite
|
Sign up to set email alerts
|

Tumour Markers and Molecular Imaging with FDG PET/CT in Breast Cancer: Their Combination for Improving the Prediction of Disease Relapse

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 65 publications
0
1
0
Order By: Relevance
“…Critics of this approach argue these studies were based upon older and less sensitive imaging tests (i.e. did not include FDG PET or PET-CT) and did not have the advantage of newer therapies such as aromatase inhibitors 68 .…”
Section: Other Imaging Modalitiesmentioning
confidence: 99%
“…Critics of this approach argue these studies were based upon older and less sensitive imaging tests (i.e. did not include FDG PET or PET-CT) and did not have the advantage of newer therapies such as aromatase inhibitors 68 .…”
Section: Other Imaging Modalitiesmentioning
confidence: 99%